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-Introduction-
Vitamin K is one of the more recent additions to 
the slowly unraveling vitamin complex, and takes its 
place in the fat soluble group along with vitamins A 
and D. The vitamin K complex has not as yet been thor-
oughly investigated, but already there has been isolated 
vitamins Kl, K3 and K4 and these substanees are being 
used clinically. 
The story of vitamin K is interesting because of 
its accidental discovery almost simultaneously in three 
independent laboratories, and its rapid development 
since that time. It is interesting because of its great 
import to serious cholemic hemorrhage which, though not 
of high incidence, has been a serious problem confront-
ing surgeons for many years. It is interesting because 
it means the prevention and cure of hemorrhage of the 
newborn, a condition which has never been well under-
stood and a serious problem to pediatricians for years. 
In presenting this subject, I have considered the 
experimental work because it is essential to an accurate 
understanding of vitamin K therapy. Much of the mater-
ial in the first section of the story has no practical 
value, but it is essential in arriving at certain con-
clusions concerning indications for vitamin K therapy. 
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Discovery or Vitamin K 
In 1929, Henrik Dam (1), working in the laborato-
ries of the University of Copenhagen, began studies of 
the sterol metabolism or the chicken. During the course 
of investigation he observed that chicks fed on a fat-
free diet for two or three weeks had a marked tendency 
to large subcutaneous and intramuscular hemorrhages and 
certain pathological changes in the stomach. He further 
noted that in all cases the growth was subnormal, and 
that in one chick the clotting time of the blood was 
markedly increased. Dam demonstrated at that time that 
the low content or sterol and rat in the diet was of no 
importance because the addition of cholesterol and cod 
liver oil did not prevent the symptoms. 
Also in the year 1929, Roderick (2), working for 
d the United States Government, was sent out to discover 
the cause of "sweet clover disease" in cattle. He found 
that cattle fed on spoiled sweet clover hay were prone 
to develop fatal hemorrhage during the dehorning process. 
The disease is characterized by the development of a 
gradually increasing prolongation of the time required 
for the blood of the animals to coagulate when it is 
drawn into tubes or in the bleeding times of injuries 
and wounds. Examination of the cattle that died reveal-
ed a central liver necrosis. He observed further that 
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all cattle that obtained alfalfa in addition did not de-
velop these hemorrhages, thereby making it evident that 
the sweet clover acquires specific disease-producing 
properties when it spoils in the curing process. In his 
subsequent analytical work, Roderick showed that the de-
layed coagulability of the blood in "sweet clover dis-
ease" involves a reduction in the plasma prothrombin and 
that the diminution parallels the delay in the coagula-
tion time. 
Apparently independently, other laboratories ob-
served the hemorrhagic chick disease in the three years 
from 1931 to 1933 (3,4,5). As in the case of Dam's dis-
covery, the finding was an incidental one, noted in the 
course of experiments in which chicks were fed purified 
diets low in fats. In 1931, while studying the effect 
of various proteins on chick growth, McFarlane, Graham 
and Hall (3) similarly noted spontaneous hemorrhages in 
their chicks. This hemorrhagic tendency was observed in 
the same laboratory by McFarlane, Graham and Richardson 
(4) in their work on the fat-soluble vitamin require-
ments of the chick. In both instances a prolonged blood 
clotting time was noted but could not be explained by 
these workers. 
It was considered originally that the hemorrhagic 
syndrome was due to sou:rvy, despite earlier reports that 
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chicks are able to synthesize vita.min C. Subsequent 
studies, however, served to rule out scurvy as well as 
other lmown vitamin deficiencies. Dam's experiments (1) 
clearly show that ascorbic acid does not prevent the de-
velopment of the hemorrhagic syndrome and the cause of 
the disease cannot be a diminished absorption of vitamin 
C from the intestine or a diminished production of the 
vitamin in the organism since subcutaneous injections of 
ascorbic acid were ineffective. It nmst be considered 
unlikely that the factor is vitamin A or D because a 
relatively large supply of cod liver oil was added to 
the basal diet of the chicks (l,3,4,5) without any 
noticeable change in the symptoms. Symptoms of poly-
neuritis or pellagra were never observed in connection 
with these diets (1,5), thus rendering it unlikely that 
the syndrome is due to a deficiency of vitamin Bl or B2. 
The exclusion of vitamin E was made by Dam (6) when he 
added large quantities of wheat germ and wheat germ oil 
to the basal diet and found that they did not afford 
complete protection against the disease. As a result of 
these experimental findings, it was first suggested by 
Dam in 1934 (1) that this hemorrhagic condition observed 
in chicks was a new dietary deficiency disease which he 
believed was due to an unlmown substance lacking in the 
fat-free diet that was essential for the proper coagula-
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tion of the chick's blood. Since the Danish word for 
coagulation is spelled "Koagulation", Dam named this un-
known substance vitamin K, a terminology which has been 
adopted generally. 
It has been mentioned that the basal diets which 
were employed by Dam (1,6), McFarlane and his coworkers 
(3,4) and Holst and Halbrook (5) in their respective 
studies, and which caused the hemorrhagic chick disease, 
were. low in fat content. However, the first definite 
evidence of the fat-soluble nature of the vitamin is 
found in the early work of McFarlane, Graham, and Richard-
son (4). They discovered that chickens fed on a diet 
containing ether-extracted fish meal suffered from the 
hemorrhagic tendencies, but that those fed on unextracted 
fish meal did not suffer the hemorrhages. Later Almquist 
and Stokstad (7) showed that fish meal and yeast, both 
of which form large parts of many of the hemorrhage-pro-
ducing purified diets, contain traces of the vitamin. 
The ether extraction of these substances before their 
incorporation in the basal diets is now perfonned for the 
successful production of the disease. In the summer of 
1935, first Dam (6) and later Almquist and Stokstad (7), 
obtained concentrates of the vitamin from natural sources 
by ether extraction, thus establishing the fat-soluble 
nature of the vitamin. These workers first used purified 
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fish meal and hog-liver fat as natural sources of the 
vitamin concentrate, describing it as occurring in the 
easily soluble non-sterol fraction of the unsaponifiable 
matter. 
Following the recognition of the hemorrhagic chick 
disease as a nutritional disorder, the relationship of 
this new dietary factor to blood clotting was soon es-
tablished. The characteristic prolonged clotting time 
incident to the disease had been observed by the origi-
nal workers (1,3,5), but it was Schpnheyder in 1936 (8) 
who first suggested that the hemorrhagic tendency is the 
result of a hypoprothrombinemia. Shortly thereafter, 
he, in collaboration with Dam and Tage-Hansen (9) of 
Copenhagen, published results of their studies on the 
mode of action of vitamin K and provided evidence which 
definitely pointed to a lowered prothrombin level in the 
hemorrhagic chick disease. They first obtained crude 
prothrombin preparations from normal chick plasma by 
acetone precipitation and by acetic acid precipitation. 
Added to a mixture of K-avitaminous chick plasma and 
thromboplastic muscle extract, the prothrombin prepar-
ations corrected the clotting defect. On the other hand, 
similar preparations from K-avitaminous chick plasma were 
without effect. Also, addition of a watery emulsion of 
a vitamin K concentrate to the plasma-thromboplastin 
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mixtures tailed to restore the clotting time to normal. 
From this they concluded that the clotting abnormality 
was due to a low plasma prothrombin level, and that 
vitamin K itself did not possess prothrombic activity. 
A more detailed study ot the prothrombin in hemor-
rhagic chick disease was carried out by Quick (10) in 
1937. On a series of chicks maintained on a vitamin K-
deticient diet, he estimated the plasma prothrombin time 
at various intervals throughout the course ot the dis-
ease. The progressive tall ot prothrombin as the dis-
ease progressed is shown 1n the following data taken 
from his experiment: 
Days on K-deti-







Prothrombin, per cent 







A distinct hemorrhagic tendency appeared when the low 
prothrombin levels were reached. The addition of a 
small amount ot alfalfa meal (5$) to the basal diet ef-
fectively restored the plasma prothrombin and cured the 
hemorrhagic tendency. 
Following this important study by Quick, rapid ad-
vances in our general knowledge of vitamin K were made 
in various laboratories by further experimental efforts. 
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-Vitamin K Deficiency in Experimental Animals-
The study of vitamin K de fie iency in chicks has 
served as the source of a great part of our present con-
cept of the vitamin, its chemical constitution and mode 
of action in the organism. Recent findings of the re-
search laboratories are important because of their 
practical application to certain disease states in the 
human, which will be discussed later. 
From Quick 1 s study of the plasma prothrombin level 
in hemorrhagic chick disease (10), and later studies of 
a similar nature (11), it was determined that hemor-
rhages do not occur until the prothrombin has declined 
to approximately ten to fifteen per cent of normal. In 
the development of the disease, the appearance of hemor-
rhage is preceded regularly by a prolongation of the 
clotting time of the whole blood.(12). Tidrick, Joyce 
and Smith (11) made a detailed study concerning the rate 
at which the plasma prothrombin level falls when newly 
hatched chicks are placed on a vitamin K-deficient diet. 
They found that the whole blood clotting time becomes 
prolonged when the prothrombin level falls to about 30~ 
of the norm.al level for chicks of the same a.ge. Thus, 
early 1n the course of the disease when the vitamin de-
ficiency is less severe, the plasma prothrombin may be 
reduced considerably and the clotting time still be 
within normal limits. It would appear that plasma pro-
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thrombin determinations are essential if any but the 
more severe grades of deficiency are to be detected. 
The production of the hemorrhagic chick disease is 
dependent on the complete removal of vitamin K from the 
diet, because the presence of minute traces will prevent 
the development of a severe deficiency. It has been 
pointed out previously that both fish meal and yeast, 
which comprise a large part of almost all basal diets, 
contain traces of the antihemorrhagic factor (7), and 
that this led to the ether extraction of these sub-
stances before their incorporation in the diet. The 
original diet employed by Dam (1) contained no fish meal 
and was an artificial diet consisting of vitamin A-free 
caseinogen, 20 parts; marmite, 10 parts; soluble starch, 
65.5 parts; salts, 4.5 parts; plus varying amounts of 
cod liver oil concentrates. The diet finally used by 
Almquist and Stokstad (7) and widely adopted by other 
investigators consists of the following: 
Fish meal, extracted with ether 
Brewer's yeast, extracted with ether 
Ground polished rice 
NaCl, plus ferrous and cupric sulfates 






This diet probably contains a minimal amount of vitamin 
K, since Almquist (13) noted the hemorrhagic chick dis-
ease in chicks on this diet as early as the fifth day 
after hatching, the average appearance of hemorrhagic 
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s-ymptoms being about the third week. Nevertheless, it 
was repeatedly observed that a certain number or chicks 
railed to develop hemorrhages or prolonged clotting 
times during a rour-week period on the diet (14) 
Recognition or the synthesis of the vitamin by 
bacteria was first reported by Almquist and Stokstad (7) 
1n their earlier work. They later showed that rice bran, 
fish meal and other foods which had been stored in a 
moist condition developed vitamin K activity (14), and 
that the incorporation of these substances in the basal 
diet prevented the development of the hemorrhagic chick 
disease. They also demonstrated the curative effect of 
putrified fish meal on vitamin K-deficient chicks with 
definite hemorrhagic s-ymptoms (15), indicating that the 
bacterial growth produced enough vitamin K to restore 
the chick to normal. Almquist, Pentler and Mecchi (15) 
in 1938 found several different types of bacteria in the 
putrified material and isolated one strain in pure cul-
ture. They inoculated this organism to wet, sterile, 
ether-extracted fish meal and found that it had a potent 
curative action on K-avitaminous chicks after a ten-day 
period of incubation. Putrefying fish meal was used 
subsequently by Osterberg and various other workers as a 
potent source of vitamin K. 
In addition to the possibility of production of the 
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antihemorrhagic factor in the diet by bacterial putri-
faction of the food, other factors influencing the in-
cidence of this dietary hemorrhagic disease must be con-
sidered. Almquist and Stokstad (16) discovered that the 
vita.min is present in the fecal matter of the chicks, 
even though they may be held on a vitamin K-free diet 
for a long period of time. They believed the vitamin to 
be produced in the lower portion of the intestine, too 
low for absorption, since many of the chicks were suffer-
ing the disease in the presence of synthesis of the 
vita.min within the body. Because of the vitamin K con-
tent of the feces, these workers found it necessary to 
prevent coprophagy among the chicks in order to produce 
the disease successfully. 
In the early experiments with vitamin K deficiency, 
Holst and Halbrook (5) and Almquist and Stokstad (7) 
noted that the severity of the disease increased with 
the rapidity of groi.vth of the chick. Another factor in-
fluencing the development of the disease, also suggested 
by Almquist and Stokstad {16), is the transfer of the 
antihemorrhagic vitamin from the diet of the hen to her 
chick. This transfer is apparently carried out through 
the yolk of the egg, and the vitamin is then stored up 
in the body of the chick in sufficient quantities to 
protect against a K-free diet for a period of about two 
-11-
weeks. Experiments were carried out in which two series 
of chicks were maintained on a K-free diet with supple-
ments of egg yolk and egg albumen, respectively, for two 
or three weeks. It was found at the end of that period 
that the yolk supplements to the basal diet had protect-
ed against the development of the chick disease, while 
the egg albumen supplements had not protected. This 
suggests the possibility that some hens may receive a 
larger supply of vitamin K in their diet and thereby 
transfer a greater protection to their chicks. 
Seasonal variations in the vitamin reserves of the 
chicks probably occur, as green plants are the moat 
potent food source of the vitamin (1). Thia would ex-
plain the observations of Thayer and associates (17) 
that the chick deficiency is most severe in the late 
winter and early spring months, and of Tidrick, Joyce 
and Smith (11) that normal chicks have a higher pro-
thrombin level in the summer than in the late tall. 
Even if the factor of varying reserves is con-
trolled, individual variations in the susceptibility of 
chicks to the deficiency have been reported by Almquist 
and his associates (14). They also demonstrated that 
although bile acids are important in the absorption of 
the vitamin, their administration failed to erase these 
individual differences. The discovery of so many factors 
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influencing the production of the disease is important 
in explaining away inconsistencies and failures to pro-
duce the disease experimentally, thus definitely es-
tablishing the role of the vitamin as a necessary diet-
ary factor for normal chicks. 
In regard to the experimental production of hemor-
rhagic disease in mammals by dietary measures alone, it 
may be said that, in general, they have not been success-
:f'u.l. Dam, Sch~nheyder and Lewis (18) fed young rats, 
quinea pigs, rabbits, dogs and pigs a K-deficient diet 
for a period of two and a half months and obtained no 
evidence of the disease. They concluded that the fact 
that certain species of animals can apparently dispense 
with vitamin K in their diet may be explained in one of 
three different ways: (l) The animal has no need of the 
vitamin, (2) the animal can synthesize the vitamin, or 
(3) the vitamin is synthesized by bacteria in the in-
testine. The last was accepted as the most likely ex-
planation because of the previous report of Almquist and 
Stokstad (16) that provided evidence for the view that 
bacterial synthesis of vitamin K occurs in the gut of 
the chick, and that it may be the reason why, under 
certain conditions, the development of the symptoms of 
the chick may be retarded. It is a lmown fact that ab-
sorption from the lower part of the intestine is much 
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greater in the mammal than in the chick and, on this 
basis, Dam and his asaocia es concluded that mammals 
rarely show vitamin K defi iency except in cases of 
faulty absorption from the intestine. 
It is interesting to ote that as early as October 
of 1935 Quick, Stanley-B and Bancroft (19) proved 
conclusively that plasma p othrombin was definitely de-
creased in persons sutferi from obstructive jaundice. 
Since he had observed an e evation of plasma prothrombin 
levels in the hemorrhagic hick disease by administration 
of vitamin K ( 10), Quick p oposed the use of the vitamin 
in obstructive jaundice o theoretical grounds, though 
he had no direct tests the validity of his pro-
posal. His theory was the idea that the de-
pletion of prothrombin in obstructive jaundice may be 
due to the absence of bil acids in the intestinal tract, 
thus causing a faulty abs of vitamin K. 
Since Quick (19) had already called attention to 
the low prothrombin level in jaundice, Hawkins and Brink-
hous (20) undertook luate the prothrombin concen-
tration in dogs after est blishing biliary fistula. They 
found that the plasma pro hrombin was at an extremely 
low level at the time of pontaneous bleeding, often 
falling to less than five per cent of a normal control 
dog. The whole blood clo ting time, which was prolonged, 
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was restored to normal by the addition of a partially 
purified prothrombin, free of calcium and thrombo-
plastin. Normal values for serum calcium and plasma 
fibrinogen were obtained, and there was no evidence of 
an excessive amount of antithrombin or of heparin. These 
data show definitely that the hemorrhagic tendency was 
the result of a prothrombin deficiency, and it was 
demonstrated that bile feeding prevented as well as 
cured this bleeding tendency. Further studies in 1938 
by Smith, Warner, Brinkhous and Seegers (21) showed that 
in the hemorrhagic disease of biliary fistula dogs the 
critical prothrombin level at which bleeding is likely 
to occur is approximately ten per cent of normal. 
Though the work just cited definitely proved the 
existence of prothrombin deficiency in biliary fistula, 
the first direct evidence in support of Quick's theory 
concerning the role of bile acids in the absorption of 
vitamin K was supplied by Greaves and Sch.~idt in 1937 
(22). These workers made observations on a group of 
operative biliary fistula rats and a group of unoperated 
rats maintained on a low fat diet for a period of 30-50 
days. The bile fistula rats, at the end of this time, 
showed a marked increase in the coagulation time of the 
blood, while the unoperated rats were entirely unaffect-
ed. Small scratches of the skin or clipping of the tail 
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of these bile fistula animals led to prolonged bleeding, 
often resulting in death unless stopped by the applica-
tion of collodion. Blood studies showed that the pro-
thrombin content of the animals was reduced to 20-30 per 
cent of normal before coagulation time was markedly in-
creased. In order to rule out a deficiency of any other 
dietary factor as a possible cause of this condition, 
vitamins A, B, D, E and G, the essential fatty acids, 
and lemon juice at levels of two cubic centimeters were 
added to the basal diet. No alteration of the hemor-
rhagic condition was observed after these supplements. 
However, when two to three cubic centimeters of beef 
bile were fed daily, a marked rise in the prothrombin 
content of the blood was noted within a period of two to 
four days after the bile was administered. Also, crude 
extracts of vitamin K (prepared from alfalfa) which had 
proven effective in preventing the hemorrhagic syndrome 
in chicks, when fed to the bile fistula rat, were ef-
fective 1n decreasing the coagulation time of the blood 
and increasing the prothrombin level. In a similar 
study of bile fistula and jaundiced rats 1n 1939, 
Greaves (23,24) concluded that the marked bleeding tend-
ency in these conditions, associated with an increased 
bleeding time and a low blood prothrombin value, is the 
result of vitamin K deficiency and can be cured by the 
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administration of vitamin K concentrates. They demon-
strated that bile salts are essential to the intestinal 
absorption of vitamin K in the rat; that is, the bile 
acts as a carrying agent for the vitamin across the 
intestinal tract. 
With attention drawn to the fact that vitamin K 
appeared to be necessary for the formation of pro-
thrombin, it became necessary to determine the source of 
prothrombin within the organism. Smith, Warner and 
Brinkhous (25) and Quick (10) in 1937 proved the source 
of prothrombin to be in the liver. By using chloroform. 
they caused a liver necrosis in dogs and were able to 
sL'1lulate the hemorrhage that occurred in "sweet clover 
disease" of cattle, the condition which Roderick (2) in-
vestigated several years before and found to have an 
associated liver damage. These workers found that the 
bleeding tendency in this toxic liver disease was the 
result of a prothrombin deficiency. In several experi-
ments of this type, platelets, antithrombin, and calcium 
studies showed normal or nearly normal values, thus 
demonstrating in a striking way that prothrombin de-
ficiency can give rise to a bleeding tendency. They 
concluded from this study that the relation of the liver 
injury to plasma prothrombin level in this disease in-
dicates that the liver is concerned in the manufacture 
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of prothrombin. Basing his views on these findings, 
Quick again advocated the use of vitamin K in treatment 
of biliary obstruction. 
Approximately two months after Hawkins and Brink-
hous (20) first published the results of their experi-
ments on biliary fistula dogs, the first successful 
treatment of human patients with obstructive jaundice 
was reported from the same laboratory (26). Other clin-
ical evidence lent its support when Butt, Snell and 
Osterberg at the Mayo clinic successiUlly demonstrated 
that postoperative bleeding 1n gall bladder surgery was 
minim.ized by the use of vitamin K. These reports of 
treatment of human cases will be considered in a later 
section. 
•Sources ot Vitamin K-
The first indication ot vitamin K occurring 1n 
nature was given by Dam in his original investigations 
ot the hemorrhagic chick disease. He demonstrated that 
the hemorrhagic syndrome could be prevented by the add-
ition ot mixed cereals to the basal diet. In later ex-
periments designed to determine the distribution ot the 
vitamin (6), he found that one of its richest sources is 
hog-liver fat. He :tUrther showed that hemp seed and 
alfalfa are particularly protective against the disease, 
while unpolished rice, sunflower seed, yellow corn and 
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rye are nearly valueless. Certain vegetables such as 
tomatoes, kale, orange peel and spinach appeared to have 
a fairly good action against the disease. 
Almquist and Stokstad (7) reported 1n 1935 that the 
addition of 0.5 per cent of dry alfalfa to the deficient 
diet prevented the appearance of symptoms, and from that 
time alfalfa has been one of the main sources of vitamin 
K concentrates. Recognition of a different antihemor-
rhagic factor resulted from the observation of Almquist 
and Stokstad (16) that rice bran, fish meal and other 
foods which had been stored in a moist condition de-
veloped vitamin K activity. That this production was 
due to the action of micro-organisms was definitely con-
cluded from Osterberg's work (27), which showed that 
large amounts of an antihemorrhagic substance were pro-
duced by bacterial putrifaction of fish meal. 
Almquist, Pentler and Macchi {15) continued the 
study of bacterial synthesis of vitamin K and found that 
the putrifaction of ether-extracted, K-free fish meal 
was accompanied by the formation of appreciable amounts 
of a fat-soluble, antihemorrhagic substance. Several 
different types of bacteria were present in the putri-
fied material. One organism producing a similar putri-
f action was isolated in pure culture and inoculated to 
beef broth, fish-meal broth, proteose-peptone broth, 
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gelatin and nutrient agar. Washed bacteria from broth 
and from nutrient agar were found to be rich sources of 
the ant1hemorrhagic factor, while the liquid media from 
which the bacteria had been removed by filtration, and 
saline used in washing the bacteria, were negative. 
They further demonstrated, by administering dried 
bacteria of several species to K-deficient chicks, that 
the antihemorrhagic activity of these organisms was from 
five to eight times that of dried alfalfa. 1hey con-
cluded that this factor is the product of bacterial 
metabolism, and, though it is also extractable by fat-
solvents, its .further similarity to the vitamin K from 
alfalfa v1as not established. 
The most extensive study of the distribution of 
vitamin K in the vegetable kingdom was carried out by 
Dam and Glavind (28) in 1938. In accordance with pre-
vious results, they found green leaves to be the most 
potent source of vitamin K among the plants. Among the 
species examined, chestnut leaves were the most potent. 
Those lower plants which contained chlorophyll appeared 
to be somewhat poorer sources than the higher plants. 
11he mushroom, which contains no chlorophyll, was very 
poor in vitamin K content. Leaves of the chestnut were 
found to lose only a small portion, if any, of their 
vitamin K activity when their chlorophyll disappeared 
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during the withering process. An experiment with germ-
inating peas showed that whereas there was an abundant 
synthesis of the vitamin in peas grown in the light, 
synthesis in peas grown in the dark occurred to a very 
limited extent. Any relationship between vitamin K and 
chlorophyll was not explained by Dam and Glavind. 
However, in more recent studies of substances with 
vitamin K activity, designated vitamins Kl and K2, 
Fieser and his associates (29) have pointed out the 
noticeable presence of large amounts of the vitamin in 
those parts of the plant containing chlorophyll. This 
fact has led Fieser to postulate that vitamin Kl con-
tains, like chlorophyll, a phytyl group. He has sug-
gested that Kl arises in nature by the condensation of 
phytol and 2-alkyl-l,4-naphthohydroquinone, both of 
which occur in plants. Fieser (29) has .further suggest-
ed that since both vitamins El and Kl contain a phytyl 
group, it is possible that there may be a close bio-
genetic relationship between the two. 
It is now generally agreed (30) that the substances 
which contain the antihemorrhagic property in the order 
of potency are: (1) Putrefied fish meal, (2) alfalfa, 
(3) hog-liver fat, (4) kale, (5) spinach, (6) dried 
carrot tops, (7) chestnut leaves, (8) tomatoes, (9) oat 
sprouts, (10) soy beans, and (11) the naphthoquinones. 
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-Bioassay-
The methods for assay of vitamin K are based on the 
prevention or cure of vitamin K deficiency in chicles. 
The criteria used for the detection of the disease have 
varied with different investigators and have been changed 
by the same investigator from time to time. Hemorrhage 
was first used as the measure of deficiency but as it 
only occurs when the prothrombin level has fallen to 10-
15 per cent that of normal chicks (10,11), only the most 
severe deficiencies are detected by this symptom. Pro-
longation of the blood clotting time was later used as a 
measure of deficiency, but we now know that a moderate 
deficiency may exist and the clotting time be normal. 
It is prolonged only if the prothrombin level of the 
blood is below about 30 to 40 per cent that of the normal 
chick (11). Dam and Glavind (31) used R-values to in-
dicate the extent of the deficiency. These values de-
pend on the amount of thromboplastin required to give a 
constant clotting time of three minutes. Almquist and 
Klose {32) recently adopted a prothrombin time measure-
ment which they believe is a great improvement over the 
clotting time tests. In view of the findings of Tidrick, 
Joyce and Smith (11), the use of the two-stage method 
for prothrombin determination would appear to give an 
even more accurate index of vitamin K deficiency. 
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A large number of curative and preventative proced-
ures for the assay of vitamin K have been devised. Each 
investigator has proposed an individual technique for 
the standardization of the vita.~in, all of which entail 
considerable detail. For this reason only the results 
of these assays will be considered here, so that a com-
parison of the various accepted standards may be made. 
The Dam unit of activity (31) refers to a special 
preparation of dried spinach, to which a value of 500 
units per gram has been arbitrarily assigned. 'IWo mg. 
of this product therefore constitutes one unit. When 
2 mg. of this standard preparation per gram of body 
weight is given daily to a highly K-deficient chick on 
three successive days, normal blood clotting is obtained. 
Dan.n's method (33,34) is that of giving varying 
levels of the test material to a group of K-deficient 
chicks fro three successive days, and at the same time 
treating another group of deficient chicks with a 
standard vitamin K concentrate prepared from alfalfa, to 
which has been assigned arbitrarily a value of 5000 
vitamin K units per gram. By comparing the blood clot-
ting times obtained by feeding the unlmown and the 
standard, the vitamin K unitage of the test material is 
determined. This would indicate that her unit of vita-
min K is the amount of material, based on the standard 
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of known potency, which when administered to chicks 
daily will bring about a coagulation time of the blood 
equal to that produced by the reference standard under 
the conditions of the test. 
Ansbacher (12) has defined his unit of vitamin K as 
"the minimum amount necessary to render the blood clot-
ting time of the vitamin K-deficient chick, weighing 70 
to 100 grams, nonn.al within six hours after administra-
tionrr. The material to be tested for vita."nin K activity 
is introduced directly into the crop, and it is fed in 
different dosage to several groups of five or more 
chicks to determine this minimum level. 
Thayer and his assoviates (35,36) define a unit of 
vitamin K as 11 that quantity of vitamin (K) which pro-
duces a clotting time of ten minutes or less in 50 per 
cent of a group of ten or more chicks which has been fed 
for the fourteen days immediately following receipt from 
the hatchery on a diet practically devoid of vitamin K11 • 
Almquist and Klose (32) have also presented a 
method of assay of vitamin K, showing that nthe recipro-
cal of the mean blood clotting time and of the mean pro-
thrombin tL~e bears a linear relation to the logarithm 
of the vitamin K level in the diet over a practical 
range of lave ls rt • 
In a report to the Council of Pharmacy and Chemistry 
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of the American Medical Association in 1939, Snell and 
Butt (37) reviewed the work done on assay of vitamin K 
and pointed out that there is not complete agreement 
among the investigators working in this field as to the 
manner of defining a unit or as to the best methods of 
assay. Since they felt that any attempt to arbitrarily 
establish a universal unit of vitamin K would be unlike-
ly to suit all investigators, it was suggested at that 
time that a consideration of units be postponed until 
exact and final knowledge of the chemical structure of 
vitamin K be known. 
In a more recent report of the status of vitamin K, 
Brinkhous (30) has attempted to correlate the various 
units of vitamin K. He tabulated the following compar-
ative values, which he states must be considered only as 
rough approximations because of discrepancies in the 
several methods of assay already referred to in the 
foregoing paragraphs. 
1 Ansbacher unit equals 20 Dam-Glavind units. 
1 Thayer-Doisy unit equals 30 Dam-Glavind units. 
1 Dann unit equals 25 Da.m-Glavind units. 
100-150 Thayer-Doisy units per kilo of diet are 
protective by the method of Almquist, Mecchi 
and Klose (14,32). 
The discovery in 1939 (38) of pure naphthoquinone 
compounds possessing vitamin K activity brought the pre-
vious proposal of Snell and Butt (37) nearer to realiza-
tion. In line with the suggestion of these men, Thayer 
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and his associates (38) proposed that one of the simplest 
and most potent of the naphthoquinones, 2-methyl-1,4-
naphthoquinone, be adopted as a standard in chick assay 
work, and all other materials be ex.pressed in terms of 
the activity of one microgram of this compound. This 
would simplify considerably the individual unit systems 
used at present by various investigators, and at the 
same time it would provide a common standard on which 
all experimental and clinical study could be based. 
-Chemistry of Vita.min K-
l. Properties. In earlier work on the purification of 
vitamin K, Dam (6) and Almquist and Stokstad (7) observ-
ed that the antihemorrhagic factor is extractable from 
natural sources by fat solvents. Attempts at isolation 
of the vita.min showed that it occurs in the non-sterol 
fraction of the lipids. They found that the vitamin is 
insoluble in water and methyl alcohol but soluble in 
many of the common organic solvents. Both acetone and 
petroleum ether proved to be satisfactory for the ex-
traction of the vitamin from natural sources. 
Following the discovery in 1935 by Almquist and 
Stokatad (7) that dried alfalfa leaf meal is an excel-
lent source of vita.min K, they prepared the first crt.ide 
concentrate of the vitamin by extraction with petroleum 
ether. Fractionation with solvents proved ineffective 
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in the separation of the pure vitamin. Likewise, chem-
ical reactions on the crude product accomplished little, 
except to show that certain common procedures could not 
be employed. Dam and Sch¢nheyder (39) and Almquist (40) 
found that saponification of the vitamin concentrates 
with alkali resulted in destruction of a large part of 
their activity, proving a lability of the vitamin toward 
alkali. 
In addition to being alkali-labile, Almquist (41) 
discovered that the vitamin is destructed by ultra-
violet light. He reported a destruction of the vitamin 
activity of alfalfa concentrates within two hours after 
exposure to sunlight, whereas no alteration was observed 
in artificial light (500 watt lamp) up to 24 hours. 
MacCorquodale and his associates (42) confirmed the 
effect of sunlight reported by Almquist, but in addition 
found that highly purified preparations of vitamin K 
dissolved in various solvents rapidly lose activity on 
exposure to the illumination of ordinary daylight bulbs. 
They :rurther observed that crude extracts of alfalfa are 
quite stable, no special precautions regarding light 
being necessary, but as the potency is increased to 500 
and 1000 units (Thayer units) per mgm., the lability is 
such that decomposition may occur in spite of all pre-
cautions regarding light. 
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One property of vita.min K, namely thermostability, 
has proved to be quite important, since it led Almquist 
(43) to introduce molecular distillation for the pur-
pose of purification. He observed that the vitamin in 
concentrates of alfalfa or hog-liver fat resists heating 
up to 120 degrees C. for twenty-four hours. Dam and 
Lewis (44) prepared a concentrate from alfalfa which 
they found to be resistant to treatment with acetic an-
hydride at 100 degrees C. for one-half hour. It was 
also noted that the vitamin is adsorbed on strong ad-
sorption media such as aluminum. oxide and magnesium 
oxide, resulting in destruction of activity. 
In a more detailed study in 1938, Klose, Almquist 
and Mecchi (45) demonstrated that the vitamin is de-
stroyed by oxidizing agents, strong acids and aluminum 
chloride, and in reactions which eliminate ethylenic 
linkages. Irreversible loss of activity due to bromin-
ation suggested to them that there was more than an 
ordinary saturation of aliphatic double or triple bonds 
in the vitamin K molecule. 'I'hey found that the material 
is non-nitrogenous and contains an aromatic nucleus; no 
phosphorous or sulfur is present in the structure. They 
concluded from their work that the properties of vitamin 
K are consistent with those of a complex, unsaturated 
hydrocarbon. 
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2. Isolation of vitamin K. In the spring of 1935, it be-
came apparent that more than one compound possesses vit-
runin K activity. McKee and his coworkers (46) reported 
the isolation of vitamins Kl and K2 from alfalfa and 
putrified fish meal respectively, and they presented 
evidence to indicate a quinoid structure for these vit-
amins. This work was repeated in the same laboratory 
shortly after by Binkley (47), and the previous findings 
were substantiated. 
Almquist and Klose (48) recently have reported that 
phthiocol, the chemical formula of which is 2-methyl-3-
hydroxy-l, 4-naphthoquinone, possesses physical and chem-
ical properties similar to pure vitamin K. It has been 
shown by these men that phthiocol is effective in pre-
venting the hemorrhagic diathesis in chicks subsisting 
on a K-deficient diet when given at levels of 20 mgm. 
per kilogram of diet. They have also suggested that 
phthiocol is the simplest member of a homologous series 
of antihemorrhagic substances. Later these investiga-
tors (49) reported that the antihemorrhagic activity of 
phthiocol lay somewhere between that of methyl naphtho-
quinone and hydroxy naphthoquinone. Their study in-
dicated that the methyl group was functionally important 
whereas the hydroxyl group seemed to reduce activity. 
They agreed that the activity of phthiocol is lower than 
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the more complex form of vita.min K existing in alfalfa. 
Ansbacher and Fernholz (50), in their study of this com-
pound, were of the same opinion. 
Recently Thayer and his associates (51), as well as 
MacCorquodale and his coworkers (52), working in Doisy 1 s 
laboratory at St. Louis University Medical School, have 
found 2-methyl-1,4-naphthoquinone the most active com-
pound studied, but when this comnound was compared with 
the natural vitamins Kl and K2, its activity was rela-
tively insignificant. They believed the structure of 
the vitamin Kl molecule to be 2-ethyl-3-phytyl-1,4-
naphthoquinone. Fieser and his coworkers (53) suggested 
that the structure of Kl was 2,6(?)-dimethyl-3-phytyl-l, 
4-naphthoquinone or the 2-mono-methyl compound. From 
the study of less complex models, Fieser, Campbell and 
Fry (29) favored the latter structure. 
Further study by Binkley and collabors.tors (54) in-
dicated that vitamin Kl is 2-methyl-3-phytyl-1,4-
naphthoquinone. The final step in the proof of this 
structure of vitamin Kl was the synthesis of the com-
pound in three separate laboratories practically simul-
taneously, by Almquist and Klose (55), MacCorquodale and 
associates (56), and Fieser (57). 'lhe natural and syn-
thetic products had the same physical and chemical prop-
erties and approximately the srune antihemorrhagic potency. 
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This comparison with the synthetic product shovrnd con-
clusively that the structure of the vitamin isolated 
from alfalfa was 2-methyl-3-phytyl-1,4-naphthoquinone. 
Vitamin K2 was isolated from putre.fying fish meal 
by MacCorquodale (42), McKee (58) and their associates 
by methods similar to those used for the isolation of 
vitamin Kl. This vitamin compound was obtained as light 
yellow crystalline plates with a melting point of 53.5-
54.5 degrees Centigrade. The potency of vitamin K2 is 
60 per cent that of vitamin Kl; that is, approximately 
600 Thayer-Doisy units per mgm. Although vitamin K2 has 
been isolated, its structure has not been identified. 
The data of McKee and coworkers (58) indicnte that it 
also is a 2,3-disubstituted-1,4-naphthoquinone. Fieser 
and coworkers (29,53), on the basis of the chemical and 
physical properties reported by McKee and associates 
(58), postulated the structure 2,3-difarnesyl-1,4-
naphthoquinone. 
3. Vitamin K activity of simple quinones and related 
products. Almquist and Klose, in June 1939 (48) report-
ed the first completely identified form of vitamin K. 
This compound is phthiocol (2-methyl-3-hydroxy-1,4-
naphthoquinone) and might be termed vita.min K3. In con-
trast to many vitamin K preparntions, phthiocol is 
slightly soluble in water. Although the compound does 
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possess vitamin K potency, its activity is not compar-
able with that of the vitamin from alfalfa. Experiment-
ally, Almquist (48) has shown that a 0.2 per cent 
buffered solution of phthiocol is effective in curing 
K-deficient chicks when given by mouth, intramuscularly 
or intravenously. 
Another synthetic naphthoquinone which has been 
studied extensively is 2-methyl-1,4-naphthoquinone, or 
vitamin K4. Amsbacher and Fernholz (50,59) showed that 
this comnound possesses activity of the same order as 
vitamin Kl. All other members of this group which have 
been tested are less than 1/20 as active as vitamin Kl. 
Most of the active synthetic compounds a.re basic-
ally 1,4-naphthoquinones or the corresponding hydro-
quinones; a few, however, are not (30). Many of the 
1,4-naphthoquinone compounds are inactive. Ansbacher 
and Fernholz (59) have shown that often relatively minor 
changes in the substituent groups of very active com-
pounds of this type may completely eliminate their vit-
amin activity. 'Illus, 2-methyl-1,4-naphthoquinone is 
very active, the 2-ethyl compound show much less activ-
ity, and the 2-propyl compound is inactive. Ansbacher 
(59) states that although the number of naphthoquinones 
which could be tested for vitamin K activity could be 
greatly increased, from results of his investigation 
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it does not appear liKely that the preparation of such 
compounds would lead to the discovery of a substance 
surpassing in activity 2-methyl-1,4-naphthoquinone. 
A complete list of the synthetic compounds, includ-
ing vitamins Kl, K3, and K4, with their respective 
formulae and activity expressed in units per milligram, 
has been published recently by Brinkhous (30) in a sum-
mary of vitamin K compounds. 
-Clinical Causes of Deficiency in Prothrombin-
In order to better understand the development of 
clinical study of hypoprothrombinemia, it will be well 
to summarize briefly the sequence of experimental in-
vestigation of vitamin K deficiency. 
That a vitamin K deficiency exists in cases of ob-
structive jaundice and bilia!"J fistula was suggested for 
the first time in 1937 (10) on theoretical grounds. ~he 
evidence then available indicated that (1) a hypopro-
thrombinemia exists in obstructive jaundice (19), bili-
ary fistula (20,21,22), and vitamin K-deficient chicks 
(8,9,10); (2) that vitamin K is a fat-soluble vitamin, 
(3) that certain of the other fat-soluble vitamins, A 
and D, require, as fats do, the presence of bile or bile 
salts in the intestine for their adequate absorption 
(60,61), and (4) that the low prothrombin level and the 
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hemorrhages can be prevented or cured in biliary fistula 
dogs by feeding bile (20). It was clear that cases of 
bleeding in biliary fistula or in obstructive jaundice 
have in connnon the absence of bile in the intestine and 
that the bleeding tendency in each is due to a diminish-
ed plasma prothrombin. On the basis of these facts, 
Quick (10) postulated, in addition, that they have a 
vitamin K deficiency, due to the lack of bile in the in-
testine. 
With the stage thus set by the investigations re-
ferred to in the preceding paragraphs, it was only log-
ical to make the next move; namely, the study of the 
effect of vitamin K in obstructive jaundice and other 
diseases of the biliary tract. 
1. Obstructive jaundice and biliary fistula. 
In October, 1937, Greaves and Schmidt experimented 
with bile fistula and jaundiced rats and presented the 
first evidence to support the earlier theory of Quick. 
They produced a hemorrhagic state in these animals by 
prolonged feeding with a low fat diet and observed a 
marked increase in the coagulation time of the blood 
when the prothrombin level had been reduced to 20 to 30 
per cent of normal. Bile feeding, as was earlier demon-
strated by Hawkins and Brinkhous (20), corrected the low 
prothrombin levels. They also found that the ad.minis-
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tration of crude extracts of vitamin K, prepared from 
alfalfa, resulted in prompt decrease of the coagulation 
time of the blood and increase of the prothrombin level. 
Further studies in June of 1938 by Smith, Warner, Brink-
hous and Seegers (21} showed that bile alone was much 
less effective in raising the plasma prothrombin level 
than a preparation containing a combination of vitamin K 
and bile or bile salts. Vitamin K alone was practically 
without effect. The equal effectiveness of bile or bile 
salts in the absorption of vitamin K indicated that the 
latter was the active material in bile (21,22,23). 
The first report of vitamin K therapy for human 
cases of obstructive jaundice and biliary fistula came 
from Warner, Brinkhous and Smith in January, 1938 (26). 
While observing their jaundiced cases over a period of 
ti~e, they fo1.llld that many showed no bleeding tendency, 
and in them the prothrombin level was usually above 50 
per cent of normal. When the prothrombin level fell 
below 35 per cent, as it frequently did in this series 
of cases, they enco1.llltered bleeding from mucous mem-
branes or hemorrhage at operation or from the wound 
af'tcr operation. The restoration of bile to the intest-
inal tract led to a gradual rise in the prothrombin 
level, requiring, on an average, a period of two weeks 
to attain normal level. This was shown in cases where 
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the obstruction was suddenly released, or in cases where 
bile was fed by mouth. On the other hand, a vitamin K 
concentrate prepared from alfalfa, plus human bile or 
bile salts, led to a rise in prothrombin from 20-40 per 
cent to 85-105 per cent of normal in six to eight days. 
It was concluded that these jaundiced patients undoubt-
edly suffer from disturbances in the digestion and ab-
sorption of fats, which in turn causes a vitamin K de-
ficiency characterized by hemorrhagic tendencies. 
Further evidence of the beneficial effects of vit-
amin K in obstructive jaundice crune practically sinml-
taneously from Butt, Snell and Osterberg of Mayo Clinic 
in February of 1938 (27,62) and from Dam and Glavind of 
Copenhagen in March of 1938 ( 63) • 
Snell (62) submitted a report on a patient who had 
obstructive jaundice due to stricture of the common bile 
duct, a badly damaged liver and a virtually incoagulable 
blood. This patient had failed to respond to the usual 
methods of treatment for the hemorrhagic diathesis of 
jaundice and was subsequently given a mixture of dried 
alfalfa and bile salts by mouth. The coagulation time 
of the patient's blood was thereupon greatly shortened 
and for a time it was hoped that surgical treatment 
could be attempted; however, the patient soon failed to 
tolerate this m:txture and the blood returned to its in-
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coagulable state. Snell believed this case to be analo-
gous to the experimental dogs of Smith, Warner and 
Brinkhous (25), in which they caused a liver necrosis 
by chloroform intoxication and noted a decreased plasma 
prothrombin with hemorrhagic tendencies. Snell believed 
that there was some justification for concluding that 
(1) the hemorrhagic state in jaundice is attributable to 
a deficiency of prothrombin which in turn is due to 
failure of absorption or utilization of some substance 
normally present in the diet which requires bile for its 
absorption; that (2) this substance may be the coagula-
tion vitamin (vitamin K); and that (3) additional toxic 
factors may deplete the supply of prothrombin from the 
liver, as in necrosis of the liver caused by chloroforru. 
Butt, Snell and Osterberg administered vitamin K 
and human bile or animal bile salts to 18 patients who 
had obstructive jaundice, and obtained good results in 
every case. In most of these 18 cases complete biliary 
obstruction and subsequent damage to the liver were 
present. In several cases the prothrombin time was not 
elevated greatly but vitamin K and bile salts were ad-
ministered as a prophylactic measure. An example of the 
prophylactic use was a case of stricture of the common 
duct and jaundice. The patient had had a severe hemor-
rhage following a previous operation elsewhere for this 
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condition. Although her prothrombin time was nearly 
within normal limits, vitamin K and bile salts were 
given as a precautionary measure. This patient went 
through her operative procedure at the clinic without 
any abnormal bleeding and, although she later died from 
a hepatic insufficiency, no abnormal bleeding was noted 
at necropsy. 
In the same study, Butt, Snell and Osterberg (27) 
pointed a case which they believed was typical of the 
usual course in a case of obstructive jaundice. In 
spite of repeated transfusions of blood the prothrombin 
time increased gradually to 140 seconds over a period of 
two weeks and remained elevated until death. At necrop-
sy a large amount of blood was found in the gastro-
intestinal tract and in the peritoneal cavity. 
In three cases of obstructive jaundice, these men 
found a rapid decrease of prothrombin time following the 
administration of vitamin K and bile salts which was 
rather striking. In one case a definitely dangerous 
prothrombin time was reduced to normal limits over a 
period of three days with the use of vitamin K and bile 
salts. Vitamin K alone was given to one case for nearly 
a week without any significant effect of the prothrombin 
time. However, 24 hours after bile was added to the K 
intake, there was a marked fall in the prothrombin time. 
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In one case in which the patient was eating heartily 
and the prothrombin time was nearly double the nor:nal 
value, administration of human bile alone resulted in 
an immediate fall in the prothrombin time. 
Butt, Snell and Osterberg (27) calculated the dose 
of vitamin K required by man by comparing the body 
weight and the weight of the intake of food to that of 
a chick for which they knew the dose necessary to pre-
vent hemorrhage. They found that, theoretically, 23 mg. 
of their material should be an adequate daily dose for 
man, but they gave orally in capsules 200 mg. daily, 
which is nearly ten times the calculated dose. In order 
to facilitate the absorption of this dosage of vitamin K, 
they gave whole human bile or rather large doses of bile 
salts ( 1000 to 4000 mg. of 11Bilron Lilly 11 daily). Human 
bile was mixed with pineapple juice and administered in 
doses of 75 to 150 cc. orally before each meal. 
Dam and Glavind {63), in their first report of vit-
amin K therapy, treated five patients with obstructive 
jaundice. Two of the cases had carcinoma of the pancreas 
which was causing pressure on the biliary tract and thus 
obstruction. All of the cases had increased clotting 
values and increased prothrombin times (high R-values). 
The parenteral introduction of 15 mg. of vita.min K daily 
rendered the clotting power of the blood normal in from 
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six to eight days and the prothrombin times returned to 
nearly normal values in the same time. It was conclud-
ed that the increased clotting time before the intro-
duction of vitamin K was due to reduced absorption of 
the vitamin from the intestine. 
Another report in 1938 by Brinkhous, Smith and 
Warner (64) confirmed the original finding of a prompt 
rise in the prothrombin level following vitamin K ther-
apy in jaundiced patients. They made a study of 27 
cases of obstructive jaundice, in most cases of which 
the plasma prothrombin levels were definitely below 
normal. In this series six cases showed a definite 
bleeding tendency and in every instance was associated 
with a marked decrease in the prothrombin level, usually 
to less than 35 per cent of normal. One case of biliary 
fistula responded to bile feeding alone with a gradual 
rise of prothrombin to a nearly normal level over a per-
iod of six weeks. In marked contrast to this was the 
very rapid rise in prothrombin level which occurred in 
obstructive jaundice cases receiving bile and alfalfa 
extract together. It was also noted that the amount of 
lowering of prothrombin is not clearly dependent upon 
the intensity or duration of the jaundice. In two cases 
of obstructive jaundice receiving vitamin K and bile 
therapy, the prothrombin rose rapidly during periods of 
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increasing jaundice, indicating that the jaundice itself 
is not the essential factor. Two patients of the entire 
series, one with a biliary cirrhosis of three years dur-
ation and another with a far-advanced malignancy of the 
liver, did not respond to alfalfa therapy. These men 
concluded that the failure of these two cases to respond 
suggests that in addition to certain dietary essentials, 
a liver of good functional capacity is needed for the 
manufacture of prothrombin. 
Snell, Butt and Osterberg (65} made a second report 
in November of 1938 on the successful use of vitamin K 
in obstructive jaundice, in which they used alfalfa as 
the source of vitamin K rather than putrefying fish meal 
as in their earlier studies. They found that their 
original concentrates of vitamin K from putrefied fish 
meal lost a large part of their potency when allowed to 
stand at room temperature or in an icebox for 30 to 90 
days, and, in an effort to find a more stable concen-
trate of vita.~in K, they selected alfalfa as the most 
practical source. With the cooperation of the Abbott 
laboratories, they obtained rather large quantities of 
concentrate of vitamin K which had been extracted from 
alfalfa with petroleum ether. This preparation had a 
potency of 20 mg. or less per kilogra~ of chick diet as 
measured by the prophylactic chick method, and 200 mg. 
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of the concentrate was equivalent to approximately 66 
grams of dry alfalfa meal, or approximately 37,500 Dam-
Glavind units. 
They reported 13 cases of actual bleeding in ob-
structive jaundice which were controlled by acL~inister­
ing this vitamin K concentrate from alfalfa in combina-
tion with bile salts. In another large group of jaund-
iced patients, an elevation of the quantitative level of 
prothrombin in the circulating blood and a reduction in 
the elevated prothrombin clotting time was effected by 
this therapy. When the concentrates were ad.ministered 
orally to 28 patients before and after surgery, none 
bled seriously and there were no deaths from hemorrhage. 
They observed this to be in marked contrast to 14 
patients who received no concentrate of vitamin K or 
bile salts preoperatively, 64 per cent of whom bled 
after surgery. They concluded that although concentrate 
of vita.min K obtained from alfalfa was at that time still 
an empiric therapeutic aid, yet with bile salts it had 
effectively prevented and controlled the hemorrhagic 
diathesis in cases of obstructive jaundice and deserved, 
therefore, a more extensive clinical use. 
Snell, Butt and Osterberg have reported that the 
greatest danger of hemorrhage following surgical opera-
tion for the relief of obstructive jaundice is between 
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the third and the ninth day after operation (66); and 
this usually may be detected by a rise in the pro-
thrombln time, which seems to occur with considerable 
regularity after operation. They observed that the ef-
fect of operation is often sufficient to decrease the 
concentration of prothrombin in the plasma below the 
critical level, with a corresponding rise in the pro-
thrombin time. Whether this is a result of injury of 
the liver resulting from anesthesia or is due to the 
loss of blood at operation, they were unable to say. 
In their experience, postoperative bleeding may begin as 
a slight oozing from the wound or gums, or as hemat-
emesis or melana; it also may become generalized and 
severe with very little warning. Under such circum-
stances transfusions of blood are indicated; their ef-
fect is to supply a small quantity of prothrombin for 
emergency use, which exerts its effect for only 6 to 12 
hours, if at all. During this interval, the administra-
tion of vitamin K and bile may be resUi.~ed, preferably by 
means of the intragastric or duodenal tubes. In add-
ition to these two forms of treatment, the importance of 
beginning an adequate food intake as soon as possible is 
obvious since the reestablishment of normal biliary flow 
into the intestine and the restoration of a normal state 
of nutrition are the ultimate considerations required 
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for cure of the hemorrhagic state. 
In 1939 there were a large number of reports on the 
successful use of vitamin K therapy in the bleeding 
tendency and hypoprothrombinemia in patients with ob-
structive jaundice. Olson (67) reported a case of ob-
struction of the connnon bile duct which was operated and 
was treated preoperatively with intravenous glucose and 
a blood transfusion. Unusual bleeding was encountered 
at the time of operation and oozing occurred for several 
days after the operation. Six days after operation a 
severe hemorrhage occurred, was controlled by a blood 
transfusion, but the ozzing recurred, and four days 
later another serious hemorrhage requiring blood trans-
fusion again occurred. Prothrombin bleeding time by the 
method of Quick was 200 seconds, whereas the normal is 
20 to 30 seconds. Vitamin K and bile salts were immedi-
ately given: 2 capsules orally t.i.d. after meals, ac-
companied by a 5 gr. tablet of bile salts. Prothrombin 
bleeding time three days later was 120 seconds, no 
further hemorrhqge had occurred, and oozing from the 
wound was decreasing. Seven days after the administra-
tion of vitamin K was instituted, the prothrombin bleed-
ing tLme was reduced to 38 seconds, which was comparable 
to a normal control, and all bleeding had stopped. The 
convalescence from that time was uneventful. 
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The case just cited, as reported by Olson (67), is 
typical of addi t:tonal reports made in the past two years 
on the continued successful use of vitarain K in patients 
with obstructive jaundice. Such reports have been made 
by Butt, Snell and Osterberg (68,69,70), Smith, Ziffren, 
Owen and Hoffman (71), Stewart and Rourke (72,73) and 
Scanlon, Brinkhous, Warner, Smith and Flynn (74). 
In addition to the studies of vitamin K deficiency 
in patients with obstructive jaundice, a number of simi-
lar studies have been made of patients with a biliary 
fistula. One of the first such cases reported, from 
the laboratory of Brinkhous, Smith and Warner (26,64) at 
the University of Iowa, had a complete external fistula 
and a hypoprothrombinemia and a bleeding tendency. With 
feeding of whole bile, the prothrombin level returned 
from a low level of 27 per cent of normal to 89 per cent 
of normal. In this case the vitamin K intake in the 
food was sufficient, though not determined, and the add-
ition of bile was necessary to permit absorption of the 
vitamin present. Successful treatment of the hypopro-
thrombinemia in these patients has been reported also by 
a number of other investigators including Butt, Snell 
and Osterberg (65), Stewart (75), Stewart, Rourke and 
Allen (72) and Smith, Ziffren, Owen, Hoffman and Flynn 
{ 74). 
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It has been reported that the administration of 
vitamin K in obstructive jaundice is less effective when 
the prothrombin deficiency is associated with extensive 
hepatic damage (25,73). That this is true was confirmed 
by two independent studies conducted in September of 
1940. Bollman, Butt and Snell (76} produced hepatic 
damage in rats by uniform exposure to a known concentra-
tion of carbon tetrachloride. Grude concentrates of 
alfalfa and 2-methyl-1,4-naphthoquinone were administer-
ed to some of these animals and in all instances failed 
to increase the level or prothrombin in the circulating 
blood. The only factor found was that extensive hepatic 
injury was associated with depletion of the level of 
prothrombin and also with failure of res1)onse to vitamin 
K. However, they did observe that in such animals 
prompt recovery occurs when the hepatotoxic agent is re-
moved and the liver repair is rapid. They concluded 
that the failure of vita.min K to maintain the prothrombin 
level of the blood and the rapid recovery to nonnal after 
discontinuation of exposure to the hepatotoxic agent in-
dicates that the liver is of fundrunental importance in 
the formation of prothrombin and in the metabolism of 
vitamin K. 
Cullen, Ziffren, Gibson and Smith (77) extended the 
study of liver intoxication, and its effect on plasma 
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prothrombin, to human beings. They made determinations 
of prothrombin levels of patients under chloroform, 
ether and cyclopropane anesthesia. A group of 6 cases 
was operated for minor surgical complications under the 
chlorofonn anesthetic. Prior to operation the pro-
thrombin levels were within normal range in all cases. 
Following operation there was a fall in every case with 
a variation of from 11 to 40 per cent and an average 
fall of 18 per cent. Neither ether nor cyclopropane 
produced any such in the uncomplicated cases which they 
reported. It was concluded that the normal functioning 
liver is essential to maintenance of prothrombin in the 
circulating blood, but the fall in the plasma pro-
thrombin level which occurs after operation in patients 
with obstructive jaundice or biliary fistulas is evi-
dently due to factors other than the anesthetic agent 
itself. 
It had been recognized for years (65) that the 
bleeding tendency in obstructive jaundice is often ob-
served within the first few days postoperatively. Al-
though often there would be no evidence of excessive 
bleeding at operation, hemorrhage might be massive and 
fatal within the next few days after operation. Butt, 
Snell and Osterberg (65) described eight patients with 
prolonged plasma prothro~bin times and postoperative 
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hemorrhage. The bleeding occurred in each caae between 
the first and fourth postoperntive days. In a few pat-
ients, hemor1"hage was not observed until later. 
The common occurrence of cholemic bleeding in the 
first few days postoperatively led to a careful study 
of the plasma prothrombin during this critical period. 
Butt, Snell and Osterberg (65,69) observed a prolonga-
tion of the plasma prothrombin time with considerable 
regularity in these patients following operation. Those 
patients in whom considerable liver damage in addition 
to obstruction of the biliary ducts was noted at the 
time of operation appeared to be most susceptible to 
postoperative hemorrhage. Stewart, Rourke and Allen 
(72) studied tha plasma prothrombin level following 
surgery in a group of 19 patients with obstructive 
jaundice. Uniformly, they :round a fall in prothrombin, 
despite the fact that a blood transfusion was given 
routinely at the time of operation. This fall averaged 
20-25 per cent, and the minimum level was reached most 
connnonly between the first and fourth days, coinciding, 
thus, with the time hemorrhage most frequently occurs. 
A number of causes for this fall in prothrombin 
after operation have been suggested. The fact that the 
fall of prothrombin in obstructive jaundice and biliary 
fistula cases is partially due to a deficiency of vita-
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min K as a result of absence of bile in the intestine 
has been adequately established by numerous studies 
(21,23,27,64). The influence of anesthesia in causing 
postoperative decline in prothrombin level has apparent-
ly been minimized through the study of Cullen and his 
associates (77). Other suggestions (64) which have been 
made include (1) increased consumption of prothrombin 
due to hemorrhage and exudate formation, without ade-
quate reserves of prothron1bin or vitamin K to restore 
the prothrombin level promptly; (2) a low bile salt out-
put by the liver and consequent malabsorption of vitamin 
K for a period after the obstruction has been relieved; 
and (3) liver damage by infection or operative trauma, 
and decreased production of prothrombin by the liver. 
Brinkhous, Smith and Warner (64) believe that because 
of these variable f~ctors some patients somewhat above 
the bleeding level before operation must be considered 
as potential bleeders, and must be treated accordingly. 
From the numerous studies on the vitrunin K defici-
ency and hypoprothrombinemia in obstructive jaundice and 
biliary fistula, it is apparent that the bleeding tend-
ency can be prevented, and in many cases it can be cured 
by treatment with vitamin K. Butt, Snell and Osterberg 
(69) have stressed the importance of preoperative and 
postoperative administration of vitamin K to avoid the 
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serious bleeding which may occur at the time of oper-
ation or soon thereafter. They administer the vitamin 
for several days prior to operation and continue this 
therapy for several days after operation, the time de-
pending on the rate of decline of the prothrombin time 
of the blood. They state that no matter what method of 
administration is used, or what concentrate of vitamin K 
is used, the importance of anticipating the danger of 
prothrombin deficiency and detecting it by laboratory 
studies will remain a prime consideration in successful 
treatment. 
Many different sources of vitamin K have been used 
in the treatment of the vitamin deficiency in obstruct-
ive, but at present the medicinal products are of two 
types. One is an extract of alfalfa and contains the 
fat-soluble natural vitamin K. The other represents a 
group of synthetic products which are more or less ef-
fective, the base being naphthoquinone. 
Dam and Glavind (63) reported the treatment of five 
cases of obstructive jaundice with K-avitaminosis by 
intramuscular injections of an emulsion of vitamin K in 
water and found it possible to resto11e the blood caog-
ulation to the normal value within a week. 
Since then Tage-Hansen (78) has studied the effect 
of vitamin K when given perorally, intramuscularly and 
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intravenously. For peroral use gelatin or starch cap-
sules containing the concentrate together with desoxy-
cholic acid were prepared. Normal coagulation was ob-
tained within two days with doses of from 100,000 to 
200,000 Dam units of vitrunin K plus 2 gm. of desoxy-
cholic acid. For injection purposes, concentrEctes hav-
ing a strength of more than one million units per gram 
were used. Intramuscular injection on two successive 
days of a watery emulsion of such a preparation repre-
senting 150,000 units of vitamin K resulted in normal 
coagulation three days after the f'irst injection. The 
intramuscular injection of' an oil solution of the vita-
min in a one day or in a three to five day period led to 
restoration of normal blood coagulation after one to two 
weeks, from 150,000 to 400,000 units in all being used 
for each patient. Intravenous injections of emulsions, 
from 15,000 to 30,000 units in one dose, yielded normal 
blood coa5-u.lation within eighteen hours, but the effect 
persisted for only a few days. Tage~Hansen concluded 
that in urgent cases it is a great advantage that two 
rapidly acting forms of application are now available: 
intravenous injection and ingestion together with bile, 
of which the first is the most efficient. 
Butt, Snell and Osterberg (65,69) have also used 
intramuscular injection of vitamin K in a few cases. 
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They administered the vitamin in peanut oil intra-
muscularly, but observed no constant prothrombin re-
sponse with this therapy as did Tage-Hansen and Dam and 
Glavind. From their experience with this method, Butt 
and his associates concluded that the intramuscular ad-
ministration of vitamin K is not practical when immedi-
ate resnonse is desired in serious hemorrhage. However, 
they believed that this method might be practically em-
ployed in cases of obstructive jaundice which require 
prolonged vitamin K therapy. 
The first reported use of intravenous therapy of a 
known vita.min K preparation was by Smith and coworkers 
(71) and practically simultaneously by Butt, Snell and 
Osterberg (68). Taey demonstrated that phthiocol, one 
of the synthetic quinone compounds, was very effective 
in doses of 40-100 mgm. A rise in prothrom.bin was ob-
served in less than 24 hours in all the cases studied. 
No toxic actions have been reported by either group of 
workers. Snell and Butt (37) made similar observations 
with intravenous injections of 5-10 mgm. of 1,4-dihy-
droxy-2-methyl-3-naphthaldehyde. This route appears to 
be ideal, especially in those cases in which there is 
nausea and vomiting, or in which there is interference 
with absorption from the intestine. 
In the past year there have been several reports of 
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the continued successful use of the na.phthoquinone com-
pounds in the therapy of obstructive jaundice. Butt, 
Snell and Osterberg (70) reported the oral and intra-
venous administration of 2-methyl-1,4-naphthoquinone, a 
compound which has been considered the most potent of the 
quinone group, practically as active as vitamin K itself. 
In most instances 1 or 2 mgm. of the substance with 5 or 
10 grains of animal bile salts constituted an adequate 
daily dose. Except in cases of liver damage, the ele-
vated prothrombin clotting time was found to return to a 
normal value within twelve, twenty-four, or thirty-six 
hours following the administration of this compound by 
mouth. Being insoluble in water, the compound was used 
intravenously by suspending it in a physiologic solution 
of sodiu.~ chloride. It was found that 1 mgm. doses 
daily by this route was effective in reducing the ele-
vated prothrombin clotting time. 
A similar study has been CTade by Rhoads and 
Fliegelman (79) in which eight cases of obstructive 
jaundice and two cases of hemorrhage of the newborn have 
been treated successfully with 2-methyl-l,4-naphtho-
q1J.inone. The compound was ad.rninistered orally in doses 
of from 1 to 4 mgm. daily. In three cases hemorrhagic 
phenomena occurred before the first dose was given, but 
in all three the hemorrhage was controlled. 
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Recently Andrus and Lord (80) have reported their 
experience with the intramuscular injection of 2-methyl-
1,4-naphthoquinone in oil for the treatment of jaundiced 
patients. The preparation which they have prepared con-
tains the K-active compound dissolved in corn oil, each 
cubic centimeter containing 1 mgm. of the active sub-
stance. Twenty-eight patients with initial prothrombin 
levels of from 5 to 70 per cent of normal were treated, 
the adults receiving 2 mgm. and the infants receiving 
0.35 to 1 mgm. of the compound intramuscularly. In many 
cases single injections of this compound restored the 
level of plasma prothrombin by as much as 48 per cent, 
and the effect was evident as early as eight hours after 
injection. It was also noted that the effect of a single 
injection may be prolonged for as long as a week, unless 
adverse factors such as operations on the biliary tract 
or other liver damage supervened. 
Another report of the use of 2-methyl-1,4-naphtho-
quinone in hypoprothrombinemia was submitted by Norcross 
and McFarland (81) in December of 1940. 'l'hey administer-
ed this compound intravenously to 22 patients and found 
it to be efficient in raising the prothrombin level by 
this route. The minimal effective dose of 2-methyl-l, 
4-naphthoquinone was found to be 2 mgin., and this dose 
given intravenously raised the prothrombin level from 50 
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per cent to 80 per cent in an average of seven and one-
half hours and to 100 per cent in an average of twenty 
hours. Further, a 2 mgm. intravenous dose kept the pro-
thrombin level above 90 per cent of normal for four or 
more days unless liver damage was present. 
It seems apparent from these more recent reports 
of the success.ful treatment or hyPoprotlFombinemia in 
obstructive jaundice with intramuscular and intravenous 
naphthoquinones, that the parenteral administration of 
these substances will eventually be generally adopted 
as the proper therapy for the hemorrhagic diathesis 
associated with this disease. 
2. Hemorrhagic disease of the newborn. 
Low and variable plasma prothrombin levels in the 
newborn and in early infancy, and the presence of an 
extreme hypoprothrombinemia in hemorrhagic disease of 
the newborn were recognized in 1937 by Brinkhaus, 
Smith and Warner (82). Since then, further studies of 
the low prothrombin level in normal infancy have in-
dicated a possible relation to a vitamin K deficiency. 
Brinkhous, Smith and Warner found the prothrombin 
level of the newly born to vary considerably in differ-
ent infants and in the same infant at different ages. 
These workers have further shown that for normal newly 
born infants the prothrombin values varry from 14 to 39 
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per cent of the level found for normal adults, while in 
a case of hemorrhagic disease the prothrombin level was 
extre~ely low, in fact less than 5 per cent of the adult 
norm (82). 
With this work in mind, Waddell and Guerry (83) 
postulated that vitamin K might conceivably be effective 
in raising the prothro!nbin content of the newly born 
infant's blood and thereby prevent both spontaneous 
hemorrhage or that initiated by the traUina of labor. 
IJhey made a study of the blood clotting times and the 
prothrombin clotting times of twenty newly born infants. 
For ten control infants the prothrombin clotting time 
and the clotting time of the blood were determined at 
varying intervals during the first week of life. To ten 
other infants vitamin K concentrate (Abbott) was admin-
istered orally, at the end of 24 hours 1 cc., at the end 
of 48 hours 0.5 cc. and at the end of 72 hours 0.5 cc. 
From a study of the prothrombin clotting rate at various 
intervals in the first week of life for the ten control 
infants, they concluded (1) that the blood of newly born 
inf ants differs markedly as regards the prothrombin 
clotting time, unusually high rates being conrr.1on, (2) 
that the blood of individual infants varies markedly on 
different days of life as regards the prothrombin clot-
ting time, (3) that the blood of certain infants is 
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peculiarly deficient in prothro~bin as determined by the 
prothrombin clotting rate and that the period of most 
marked deficiency is between the ages of 48 hours and 
72 hours and (4) that after the fifth day the rate tends 
to fall to an apparently common level. They believed 
that the last fact strongly suggests a relationship be-
tween hemorrhagic disease of the newly born and the pro-
thrombin content of the blood, in that hemorrhagic dis-
ease rarely occurs after the fifth day of life, the time 
at which the prothrombin clotting rate of the control 
infants appeared to approach a common level. Tile most 
important point in this study was brought out by a com-
parison of the blood clotting times and prothrombin clot-
ting times of the control group and the vitamin K treated 
group in the first week of life. The generally lower 
clotting values and their strikingly common level for 
the treated infants was very evident. Waddell and 
Guerry concluded from this study that the prevention and 
treatment of spontaneous hemorrhage, concealed or ap-
parent, associated with a high prothrombin clotting and 
blood clotting time and appearing within the first week 
of life, should be easily effected with vitamin K. 
Hellman and Shattles (84) and Shattles, Delfs and 
Hellman at Johns Hopkins Hospital confirmed the finding 
of a low prothror~bin level at birth. Cord blood, in 
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their series, contained about 22 per cent as Im1Ch pro-
thrombin as in the mother's blood. Shettles, Hellman 
and Delfs (85) also have studied a total of 17 premature 
infants and have found the average prothrombin level to 
be only about one-third that of full-term infants; that 
is, less than 10 per cent of the values of the mothers. 
Having established the efficacy of vita.min K ther-
apy in the hypoprothro,:ibinemia of the newborn, Hellman, 
Moore and Shettles, in June of 1940, made a study to 
compare the ability of various naphthohydroquinone deri-
vatives in raising the plasma prothrombin levels of new-
born infants when fed to their mothers during labor.(86) 
For this purpose they used the following synthetic com-
pounds: (1) 2-methyl-1,4-naphthoquinone, (2) 2-methyl-
3-phytyl-1,4-naphthoquinone and (3) 2-methyl-1,4-naphtho-
hydroquinone dipropionate. In 2000 unit doses, these 
three synthetic comDounds given by mouth, and one given 
intravenously, were shown to elevate significantly the 
infant plasma prothrombin level when given to the mothers 
during labor. They found that the infant plasma pro-
thrombin was raised to the highest level by the adminis-
tration of the substance having the simplest chemical 
structure; namely, 2-methyl-l, 4-naphthoquinone. 'I'his is 
is in agreement with previous studies in which the hypo-
prothrombinemia of jaundice was treated with quinones. 
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More recent studies of vitamin K therapy in the 
treatment of hemorrhage of the newborn have confirmed 
the previous reports of successful prevention of danger-
ously low levels of plasma prothrombin. Reports by 
Poncher and Kato (87), Waddell and Lawson (88), Maumence, 
Hellman and Shettles (89), Lawson (90) and Kato and 
Poncher (91) all indicate that the treatment of hypo-
prothrombinemia. of the newborn, particularly in cases of 
apparent hemorrhage, is rapidly becoming an accepted 
measure of therapy. 
3. Other conditions. 
Recently, Sprue and Hemophilia have been considered 
as conditions in which vitamin K therapy might be in-
dicated. All that needs to be said in regard to this 
possibility is that many of the investigators already re-
ferred to in previous sections have found no indications 
for vitamin K therapy for these diseases up to the pres-
ent time. 
-Conclusion-
Vitamin K, a fat-soluble vitamin, is essential for 
the maintenance of a normal concentration of prothrombin 
in the blood. Animal experimentation and clinical studies 
have shown that certrrin hemorrhagic tendencies are due to 
a low plasma prothrombin resulting from a vitamin K de~ 
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ficiency • Absorption of this fat-soluble vitamin is 
dependent on the presence of bile in the intestine 
rather than on the adequacy of vitamin K in the diet. 
Lowered prothrombin concentration may occur in condi-
tions in which extensive intestinal lesions interfere 
with absorption or, more frequently, in conditions in 
which bile is excluded from the intestine by obstruction 
of the common bile duct. In such cases the administra-
tion of vitamin K will restore the normal prothrombin 
level. Bile salts, of course, must be given along with 
the orally administered vitamin in cases in which bile 
is not present in the intestine; otherwise the vitamin 
will not be absorbed. Recent work also indicates that 
newborn infants have a vitamin K deficiency in the first 
few days of life and that the administration of vitamin 
K will prevent and cure the hemorrhe.r;ic diathesis in at 
least many cases of hemorrhagic disease of the newborn. 
More generally, it is safe to say that vitamin K 
therapy is only indicated in those conditions of hemor-
rhage or potential hemorrhage in which there is definite 
hypoprothrombinemia. Prothrombin metabolism is inter-
fered with when: 
(1). Vitamin K is inadequate in the diet. 
( 2). Bile is not pre sE;nt in the upper intestinal 
tract. 
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(3). Fat digestion is interfered with. 
(4). Normal mucosa of the upper intestinal tract 
is destroyed. 
(5). Liver function is interfered with. 
When the above conditions are responsible for a hypo-
prothrombinemia, then vitamin K and bile are indicated. 
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